EFFECT OF P-GLYCOPROTEIN EXPRESSION ON SENSITIVITY TO HORMONES IN MCF-7 HUMAN BREAST-CANCER CELLS

被引:54
|
作者
CLARKE, R
CURRIER, S
KAPLAN, O
LOVELACE, E
BOULAY, V
GOTTESMAN, MM
DICKSON, RB
机构
[1] NCI,DIV CANC BIOL DIAG & CTR,CELL BIOL LAB,BETHESDA,MD 20892
[2] NCI,DIV CANC BIOL DIAG & CTR,MOLEC BIOL LAB,BETHESDA,MD 20892
[3] GEORGETOWN UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,WASHINGTON,DC 20007
[4] NCI,DIV CANC TREATMENT,BETHESDA,MD 20892
关键词
D O I
10.1093/jnci/84.19.1506
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Data obtained from studies of primary human breast cancers and established cell lines indicate that overexpression of the MDR1 gene (also known as PGY1) is associated with decreased expression of steroid hormone receptors and increased expression of epidermal growth factor (EGF) receptors. Other study results indicate that both progestins and triphenylethylene antiestrogens may be substrates for P-glycoprotein, the product of the MDR1 gene. These findings together suggest an association between overexpression of the MDR1 gene and cross-resistance to progestin and antiestrogen therapies. Purpose: This study was designed to determine (a) the ability of MDR1 expression to alter tumor sensitivity to hormone therapy and (b) the role of MDR1 expression in expression of functional hormone receptors in human breast cancer. Methods: We transduced MCF-7 cells with MDR1 complementary DNA, using a retroviral vector directing the constitutive expression of the MDR1 gene. Transduced cells (MCF-7MDR1) were examined for ability to produce P-glycoprotein, expression of steroid hormone receptors, and responsivity to antiestrogens. For comparison, we used MCF-7ADR human breast cancer cells, which overexpress MDR1 and have also lost the requirement for 17beta-estradiol supplementation to form tumors in nude mice. We also investigated the level of EGF-R mRNA expression by using a sensitive RNase protection analysis. Results: MCF-7MDR1 cells retained both estrogen receptor and progesterone receptor expression as well as sensitivity to 4-hydroxytamoxifen. Expression of the estrogen-inducible pS2 and EGF receptor genes was similar in parental MCF-7 and transduced MCF-7MDR1 cells. EGF receptor expression was increased, and pS2 expression was lost (undetectable) in MCF-7ADR cells. Conclusions: The data indicate that overexpression of the MDR1 gene alone confers a multidrug-resistant phenotype, but it does not directly result in either cross-resistance to antiestrogens or a loss of steroid hormone receptor expression. Implications: MCF-7MDR1 cells provide an important model for study of the interactions of cytotoxic drugs, hormones, and the MDR1 glycoprotein in human hormone-responsive breast cancer cells.
引用
收藏
页码:1506 / 1512
页数:7
相关论文
共 50 条
  • [1] Polyprenol could inhibit P-glycoprotein in human MCF-7 breast cancer cells
    Kuznecovs, I.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 37 - 37
  • [2] Dolichyl phosphate dependent P-glycoprotein expression in Doxorubicin resistant MCF-7 breast cancer cells
    Kuznecovs, I.
    Kuznecovs, S.
    Jegina, K.
    Kuznecova, G.
    [J]. EJC SUPPLEMENTS, 2008, 6 (09): : 86 - 86
  • [3] A NEW FUNCTIONAL-ROLE FOR P-GLYCOPROTEIN - EFFLUX PUMP FOR BENZO(A)PYRENE IN HUMAN BREAST-CANCER MCF-7 CELLS
    YEH, GC
    LOPACZYNSKA, J
    POORE, CM
    PHANG, JM
    [J]. CANCER RESEARCH, 1992, 52 (23) : 6692 - 6695
  • [4] Dolichyl phosphate and polyprenol could inhibit P-glycoprotein in human MCF-7 breast cancer cells
    Kuznecovs, I.
    Jegina, K.
    Kuznecovs, S.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 100 - 100
  • [5] Effect of Polyprenol on DPAGT1 Expression, P-glycoprotein and E-cadherin in MCF-7 Breast Cancer Cells
    Kuznecovs, I.
    Kuznecovs, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S101 - S101
  • [6] MELATONIN AUGMENTS THE SENSITIVITY OF MCF-7 HUMAN BREAST-CANCER CELLS TO TAMOXIFEN INVITRO
    WILSON, ST
    BLASK, DE
    LEMUSWILSON, AM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02): : 669 - 670
  • [7] INCREASING SENSITIVITY OF MCF-7/DOX CELLS TOWARDS DOXORUBICIN BY HESPERETIN THROUGH SUPPRESSION OF P-GLYCOPROTEIN EXPRESSION
    Sarmoko
    Putri, Dyaningtyas Dewi Pamungkas
    Susidarti, Ratna Asmah
    Nugroho, Agung Endro
    Meiyanto, Edy
    [J]. INDONESIAN JOURNAL OF PHARMACY, 2014, 25 (02): : 84 - 90
  • [8] QUERCETIN POTENTIATES THE EFFECT OF ADRIAMYCIN IN A MULTIDRUG-RESISTANT MCF-7 HUMAN BREAST-CANCER CELL-LINE - P-GLYCOPROTEIN AS A POSSIBLE TARGET
    SCAMBIA, G
    RANELLETTI, FO
    PANICI, PB
    DEVINCENZO, R
    BONANNO, G
    FERRANDINA, G
    PIANTELLI, M
    BUSSA, S
    RUMI, C
    CIANFRIGLIA, M
    MANCUSO, S
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (06) : 459 - 464
  • [9] Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells
    Mealey, KL
    Barhoumi, R
    Burghardt, RC
    Safe, S
    Kochevar, DT
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 755 - 761
  • [10] Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol
    Xu, Dong
    Lu, Qinghua
    Hu, Xun
    [J]. CANCER LETTERS, 2006, 243 (02) : 274 - 280